World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
13893
World Ranking
2781
National Ranking
244

Michael J. Doenhoff publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael J. Doenhoff sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 215 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael J. Doenhoff D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael J. Doenhoff sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael J. Doenhoff is affiliated with the University of Nottingham in the United Kingdom. Their research primarily focuses on areas within immunology, microbiology, and medicine, with a special emphasis on parasitology and infectious diseases.

The subfields of study associated with their work include parasitology, ecology, immunology and allergy, infectious diseases, and small animals. This range highlights a multidisciplinary approach to understanding host-parasite interactions and disease mechanisms.

Major topics explored in their research encompass parasites and host interactions, parasite biology and host interactions, parasitic diseases research and treatment, food allergy and anaphylaxis research, allergic rhinitis and sensitization, vector-borne infectious diseases, and helminth infection and control.

Several frequent co-authors have collaborated with Michael J. Doenhoff, including Marwa H. El-Faham, Fatou Gai, Joseph E. Igetei, Sarah Richter, and Franco H. Falcone.

Among the journals where Michael J. Doenhoff has published are "Scientific Reports" with two publications, "PLoS Neglected Tropical Diseases," and "Pathogens."

The recent papers authored or co-authored by Michael J. Doenhoff are:

  • Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development, 2020, PLoS Neglected Tropical Diseases
  • Antigenic cross-reactivity between Schistosoma mansoni and allergenic invertebrates putatively due to shared glycanic epitopes, 2020, Scientific Reports
  • Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages-A Tool to Decipher Schistosoma mansoni Infection Stages, 2021, Pathogens
  • Author Correction: Antigenic cross-reactivity between Schistosoma mansoni and allergenic invertebrates putatively due to shared glycanic epitopes, 2020, Scientific Reports

Best Publications

  • Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.

    Michael J Doenhoff;Donato Cioli;Jürg Utzinger

  • Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific

    Padraic G. Fallon;Michael J. Doenhoff

  • Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses.

    Bart Everts;Georgia Perona-Wright;Hermelijn H. Smits;Cornelis H. Hokke

  • Schistosoma mansoni: chemotherapy of infections of different ages.

    A.A. Sabah;Cathy Fletcher;G. Webbe;M.J. Doenhoff

  • Serum amyloid P-component is an acute-phase reactant in the mouse

    M. B. Pepys;Marilyn Baltz;K. Gomer;A. J. S. Davies

  • Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies?

    Michael J. Doenhoff;Peter L. Chiodini;Joanne V. Hamilton

  • SELECTIVE TRIGGERING OF HUMAN T AND B LYMPHOCYTES IN VITRO BY POLYCLONAL MITOGENS

    Melvyn Greaves;George Janossy;Michael Doenhoff

  • Resistance of Schistosoma mansoni to praziquantel: is there a problem?

    Michael J. Doenhoff;John R. Kusel;Gerald C. Coles;Donato Cioli

  • Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.

    Fallon Pg;Sturrock Rf;Niang Ac;Doenhoff Mj

  • Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.

    M. J. Doenhoff;P. Hagan;D. Cioli;V. Southgate

  • Molecular Characterization of an Interleukin-4-inducing Factor from Schistosoma mansoni Eggs

    Gabriele Schramm;Franco H. Falcone;Achim Gronow;Karin Haisch

  • Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.

    Michael J Doenhoff;Livia Pica-Mattoccia

  • The thymus and circulating lymphocytes of mice.

    M. J. Doenhoff;A. J. S. Davies;E. Leuchars;V. Wallis

  • Cutting Edge: IPSE/alpha-1, a Glycoprotein from Schistosoma mansoni Eggs, Induces IgE-Dependent, Antigen-Independent IL-4 Production by Murine Basophils In Vivo

    Gabriele Schramm;Katja Mohrs;Maren Wodrich;Michael J. Doenhoff

  • Serodiagnosis of Imported Schistosomiasis by a Combination of a Commercial Indirect Hemagglutination Test with Schistosoma mansoni Adult Worm Antigens and an Enzyme-Linked Immunosorbent Assay with S. mansoni Egg Antigens

    Tom van Gool;Hans Vetter;Tony Vervoort;Michael J. Doenhoff

  • Origin and diversification of the human parasite Schistosoma mansoni.

    Jess A. T. Morgan;Randall J. Dejong;Grace O. Adeoye;Ebenezer D. O. Ansa

  • Diagnosis of schistosomiasis : antibody detection, with notes on parasitological and antigen detection methods

    J. V. Hamilton;M. Klinkert;M. J. Doenhoff

  • Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates.

    Donato Cioli;Sanaa S Botros;Katherine Wheatcroft-Francklow;Amadou Mbaye

  • Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infections: stage specificity of the reactivity of immune serum in T-cell deprived mice

    M.J. Doenhoff;S. Pearson;D.W. Dunne;Q. Bickle

  • Schistosoma mansoni: Reduced efficacy of chemotherapy in infected T-cell-deprived mice

    A.A. Sabah;C. Fletcher;G. Webbe;M.J. Doenhoff

  • Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice

    M.J. Doenhoff;A.A.A. Sabah;Cathy Fletcher;G. Webbe

  • Identification and partial purification of an antigen (ω1) from Schistosoma mansoni eggs which is putatively hepatotoxic in T-cell deprived mice.

    D.W. Dunne;S. Lucas;Q. Bickle;S. Pearson

  • IPSE/alpha-1: A major immunogenic component secreted from Schistosoma mansoni eggs☆

    G. Schramm;A. Gronow;J. Knobloch;V. Wippersteg

Frequent Co-Authors

Quentin D. Bickle
Quentin D. Bickle London School of Hygiene & Tropical Medicine
Helmut L. Haas
Helmut L. Haas Heinrich Heine University Düsseldorf
Padraic G. Fallon
Padraic G. Fallon Trinity College Dublin
Manfred Wuhrer
Manfred Wuhrer Leiden University Medical Center
Rudolf Geyer
Rudolf Geyer University of Giessen
David W. Dunne
David W. Dunne University of Cambridge
Cornelis H. Hokke
Cornelis H. Hokke Leiden University Medical Center
André M. Deelder
André M. Deelder Leiden University Medical Center
Peter L. Chiodini
Peter L. Chiodini London School of Hygiene & Tropical Medicine
Gerald C. Coles
Gerald C. Coles University of Bristol

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open diverse career pathways in healthcare and biomedical research. Nurses with a background in immunology may consider advancing their qualifications through accelerated RN to NP programs, which can prepare them for specialized roles in immunologic patient care and management.

Individuals without a nursing background can also enter the field by enrolling in online nursing programs for non nurses. These programs offer a pathway to gain essential nursing skills while accommodating different educational histories.

For those starting their nursing journey, options like the easiest ABSN program to get into provide a faster route to becoming a registered nurse. Similarly, the fastest and easiest LPN programs are ideal for individuals seeking to quickly enter practical nursing, which supports clinical settings where immunology knowledge is increasingly valuable.

Choosing the right educational pathway involves balancing time, career goals, and entry requirements. These options illustrate how flexible and accessible nursing and healthcare education have become, complementing studies and careers centered around immunology.

Best Scientists Citing Michael J. Doenhoff

Trending Scientists

Recently Published Articles